Gormedic ApS: Financial statements 2025
CVR: 39100002
Source: annual report 2025, Danish Business Authority
01/04/2024 – 31/03/2025
Gormedic ApS (CVR 39100002) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 408,506 and a net result of DKK -494,811 compared with DKK -359,886 the year before. That is an increase of 61.4% compared with the year before. Equity in the 2025 report amounted to DKK 581,204. The solvency ratio was 29.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 408,506
- Profit/Loss
- DKK -494,811
- Equity
- DKK 581,204
- Total Assets
- DKK 1,980,982
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 409 t. | -495 t. | 581 t. | 2 |
| 2024 | - | 253 t. | -360 t. | 1.1 mio. | 1 |
| 2023 | - | 983 t. | 336 t. | 1.4 mio. | 1 |
| 2022 | - | 215 t. | -381 t. | 1.1 mio. | 1 |
| 2021 | - | 632 t. | -30 t. | 1.5 mio. | 1 |
Official annual report
How creditworthy is Gormedic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Gormedic ApS
Gormedic ApS is a Danish company of the type Anpartsselskab based in Nørresundby, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Oleg Gordienko. The board consists of Oleg Gordienko (chair). The company is owned by Oleg Gordienko. According to the 2026 annual report, the company had an average of 2 employees. In 2026, the company reported a gross profit of DKK 1,056,010 and a net result of DKK -293,728 compared with DKK -494,811 the year before. Equity in the 2026 report amounted to DKK 287,476.